A triptan too far?

被引：81

作者：

Goadsby, PJ ^{[1
]}

机构：

[1] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1998年 / 64卷 / 02期

关键词：

D O I：

10.1136/jnnp.64.2.143

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：143 / 147

页数：5

共 52 条

[1] MONOAMINE OXIDASE INHIBITION IN TREATMENT OF MIGRAINE [J].

ANTHONY, M ;

LANCE, JW .

ARCHIVES OF NEUROLOGY, 1969, 21 (03) :263-&

[2]

ANTHONY M, 1969, RESEARCH CLINICAL ST, V2, P29

[3]

Armitage P., 2001, STAT METHODS MED RES, V4th

[4]

BAX ND, 1997, BR J CLIN PHARM, V19, P597

[5]

Berde B, 1978, HDB EXPT PHARM, V49

[6] Pathophysiology and management of the serotonin syndrome [J].

Brown, TM ;

Skop, BP ;

Mareth, TR .

ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) :527-533

[7]

CABARROCAS X, 1997, CEPHALALGIA, V17, P420

[8] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT [J].

COOK, RJ ;

SACKETT, DL .

BRITISH MEDICAL JOURNAL, 1995, 310 (6977) :452-454

[9] The clinical pharmacokinetics of zolmitriptan [J].

Dixon, R ;

Warrander, A .

CEPHALALGIA, 1997, 17 :15-20

[10] RATIONALE FOR THE USE OF 5-HT1-LIKE AGONISTS IN THE TREATMENT OF MIGRAINE [J].

FENIUK, W ;

HUMPHREY, PPA ;

PERREN, MJ ;

CONNOR, HE ;

WHALLEY, ET .

JOURNAL OF NEUROLOGY, 1991, 238 :S57-S61

← 1 2 3 4 5 6 →